I
T IS WELL DOCUMENTED that trophic hormone stimulation of testicular Leydig cells induces cAMP formation followed by activation of protein kinase A (PKA) (1) . PKA phosphorylates the transcription factors regulating gene expression of the steroidogenic acute regulatory (StAR) protein (2) , which is critical for transfer of the substrate cholesterol to the inner mitochondrial membrane to initiate steroidogenesis (3) (4) (5) . Studies in the recent two decades demonstrated that trophic hormones also induce arachidonic acid (AA) release (6 -9) , and AA metabolites transduce signals to the nucleus to regulate StAR gene expression (10, 11) . Both the PKA phosphorylation and the AA-mediated pathways are required for trophic hormone-induced signal transduction, with neither pathway alone being sufficient for StAR gene expression and steroid hormone production (12) .
In the AA-mediated signaling pathway, AA is mainly catalyzed by three enzymes, lipoxygenase, epoxygenase, and cyclooxygenase, respectively, and metabolized to various products (13) . It has been reported that cAMP stimulation of MA-10 Leydig cells significantly increased 5-lipoxygenasegenerated AA metabolites 5-hydroperoxyeicosatetraenoic acid and 5-hydroxyeicosatetraenoic acid and also epoxygenase-produced metabolites 5,6-epoxy-8Z,11Z,14Z-eicosatrienoic acid, 8,9-epoxy-5Z,11Z,14Z-eicosatrienoic acid, and 11,12-epoxy-5Z,8Z,14Z-eicosatrienoic acid. Each of these AA metabolites significantly enhanced cAMP-stimulated StAR gene expression and steroid hormone production (14, 15) . In addition, inhibition of 5-lipoxygenase or epoxygenase activity depressed StAR gene expression and steroidogenesis in MA-10 cells (12) . In contrast to the stimulatory effect of these two metabolic enzymes of AA, the third enzyme, cyclooxygenase-2 (COX2, an isoform of cyclooxygenase) acts to inhibit StAR gene expression. Inhibition of COX2 activity dramatically increased cAMP-stimulated StAR gene expression and steroidogenesis (16) . Overexpression of COX2 in MA-10 cells significantly depressed StAR gene expression and steroid hormone production. Moreover, the age-related decline in testosterone biosynthesis is associated with an increase in COX2 expression in Leydig cells and was reversed by inhibition of its activity (17) . The evidence provided by these studies demonstrated a COX2-dependent inhibition of cAMP-stimulated StAR gene expression and steroidogenesis in Leydig cells.
The mechanism responsible for the inhibitory effect produced by COX2 on steroidogenesis has not been well eluci-dated at this time. An earlier study reported an inhibitory effect of a COX2-generated AA metabolite, prostaglandin (PG) F2␣, on LH-stimulated steroidogenesis in rat Leydig cells (18) . Recently, it was reported that incubation of hamster Leydig cells with PGF2␣ resulted in decreases in human chorionic gonadotrophin (hCG)-stimulated StAR protein and testosterone production (19) . Further studies revealed that PGF2␣ induced the expression of DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome gene 1), a powerful transcriptional repressor of StAR gene transcription (20, 21) . PGF2␣ also induced another repressor, c-Fos, that binds to the StAR promoter and inhibits StAR gene expression (22) . These studies suggested that the AA metabolites generated by COX2 and its downstream enzymes may be involved in the inhibitory effect on StAR gene expression. To understand the role of another enzyme downstream of COX2, thromboxane A synthase (TBXAS), in steroidogenesis, we inhibited its expression using RNA interference (RNAi) and also blocked its activity using an inhibitor. The results from the present study indicated that inhibition of TBXAS expression or activity enhanced cAMPstimulated StAR gene expression and steroidogenesis in MA-10 mouse Leydig cells. (23) . The monoclonal antibody against DAX-1 protein was a generous gift from Dr. P. Sassone-Corsi (Université Louis Pasteur, Strasbourg, France). Goat antirabbit IgG antibody conjugated with horseradish peroxidase was purchased from Biosource (Camarillo, CA). Horse serum was purchased from Invitrogen (Grand Island, NY). The dual-luciferase reporter assay system was purchased from Promega (Madison, WI). Other common chemicals used in this study were obtained from either Sigma or Fisher Chemicals (Pittsburgh, PA).
Materials and Methods Reagents

Cell culture
The MA-10 mouse Leydig tumor cell line was a generous gift from Dr. Mario Ascoli (Department of Pharmacology, University of Iowa, College of Medicine, Iowa City, IA). The cells were cultured in 12-well culture plates in Waymouth's MB/752 medium containing 15% horse serum as previously described (24) in an incubator at 37 C and 5% CO 2 . Before each experiment, the medium was replaced with serum-free Waymouth's medium.
RNAi
The small interference RNAs (siRNAs) were obtained from Ambion (Austin, TX) for RNAi of mouse TBXAS expression (Ambion siRNA ID 187220, corresponding to TBXAS DNA sequence 5Ј-CCCAAGATGG-TAGCAGACA-3Ј) and for siRNA control (catalog item 4611). MA-10 cells at 0.2 ϫ 10 6 cells per well in 12-well plates were cultured overnight. The siRNAs were introduced into the cells using the X-tremeGENE siRNA transfection reagent (Roche, Indianapolis, IN) following the manufacturer's instructions. The transfected cells were cultured for 3 d before experiments.
Steroid production
MA-10 cells were cultured for 30 min in serum-free Waymouth's medium in 12-well plates with or without the TBXAS inhibitor furegrelate (as described in the figure legends), and then 0.2 mm dbcAMP was added to the cultures for 6 h. The medium was collected at the end of each experiment and stored at Ϫ80 C. Progesterone concentrations in the medium were determined by RIA (25) and expressed as picograms per microgram cellular protein.
Enzyme immunoassays
MA-10 cells cultured in Waymouth's medium in 12-well plates were treated with 0.8 mm furegrelate for 6 h. Then, the medium was collected. The concentrations of TBX B2 or PGF2␣ in the medium were determined using a chemiluminescence enzyme immunoassay kit or an enzyme immunoassay kit, respectively, following the manufacturer's instructions (Assay Designs, Ann Arbor, MI), and expressed as picograms per milligram cellular protein.
Western blot analysis
StAR protein and DAX-1 protein in MA-10 cells were detected by Western blot analysis as described previously (26) . The DAX-1-or StARspecific bands were scanned and quantitated as integrated OD (IOD). The average IOD for each treatment was calculated and expressed as fold increase over control. Western blot analysis experiments were performed at least three times, and the results of one representative experiment are shown for each figure.
Transfection
MA-10 cells were cultured in 12-well plates (0.2 ϫ 10 6 cells per well) overnight. The cells in each well were transfected with 0.5 g DNA of the StAR promoter/luciferase plasmid PGL2/StAR expressing firefly luciferase driven by the Ϫ966-bp sequence of the StAR promoter (27) . Transfections also included 6.0 ng of the pRL-SV40 vector DNA (a plasmid that constitutively expresses Renilla luciferase, a control reporter under the control of the SV40 promoter; Promega). Transfections were performed using FuGENE6 transfection reagent (Roche, Indianapolis, IN) following the manufacturer's instructions. After 48 h in culture, the cells were used for additional experiments.
Luciferase assays
After the experiments, the cells were washed three times with ice-cold PBS and lysed with passive lysis buffer (Promega). The supernatants were used for luciferase assays using a dual luciferase reporter assay system following the manufacturer's instructions (Promega). The relative light units (RLU, determined by dividing the reading from the PGL2/StAR promoter by the reading from Renilla luciferase) were measured using a TD-20/20 luminometer (Turner Designers, Sunnyvale, CA). StAR promoter activities are expressed as fold increases over the RLU of control.
RT-PCR
In experiments designed to determine StAR or TBXAS mRNA expression, cells were washed three times with cold PBS and used for total RNA purification using TRIzol reagent in accordance with the manufacturer's instructions (Invitrogen, Carsbad, CA). The first-strand cDNA was synthesized from total RNA using the reverse transcription system (Promega). PCR for StAR was performed as previously described (28) . PCR for TBXAS was performed with forward primer 5Ј-CCCTGTC-CTCTTCTGAGTGC-3Ј and reverse primer 5Ј-TGAAATCACCATGTC-CAGATAC-3Ј for 30 cycles of 94 C for 1.5 min, 56 C for 1.5 min, and 72 C for 2.5 min, followed by incubation at 72 C for 15 min. ␤-Actin was used as internal marker in PCR for StAR or TBXAS.
Statistical analysis
Each experiment was repeated at least three times. Statistical analysis of the data was performed with ANOVA followed by Tukey significant difference test using the GraphPad Prism 4 system (GraphPad Software, San Diego, CA). The data are shown as the mean Ϯ se.
Results
Steroidogenesis and StAR protein expression
To determine the effects of TBXAS activity on StAR protein expression and steroidogenesis, MA-10 cells were incubated for 30 min in the medium containing a TBXAS inhibitor, furegrelate, and then 0.2 mm dbcAMP was added to the culture for 6 h. The incubation of MA-10 cells with the inhibitor significantly inhibited TBXAS activity but did not reduce PGF2␣ production (Fig. 1C) . Similar results were obtained in previous studies that demonstrated the specificity of furegrelate in inhibition of TBXAS activity (29 -32) . The results in Fig. 1 , A and B, show that although 0.2 mm dbcAMP alone did not induce a significant increase in steroidogenesis, inhibition of TBXAS activity markedly increased StAR protein expression in a concentration-dependent manner. The increase in StAR protein occurred concomitantly with a significant increase in steroid hormone production. When the concentration of furegrelate in the culture was increased to 0.8 mm, progesterone production by the cells was increased to 17-fold over that by the cells treated with 0.2 mm dbcAMP alone. To determine whether furegrelate affected the activities of steroidogenic enzymes in MA-10 cells, 22(R)hydroxycholesterol, a compound that can readily diffuse to the mitochondrial inner membrane in the absence of StAR protein, was added to each treatment. The RIA results indicated that in the presence of 22(R)hydroxycholesterol, there was no significant difference in steroid production among the treatments (Fig. 1B) , indicating that the activities of steroidogenic enzymes were not affected by furegrelate.
StAR gene transcription
Luciferase assays of StAR promoter activity and RT-PCR analysis of StAR mRNA levels were performed to determine whether the TBXAS inhibitor affected StAR gene transcription. Similar to the results shown in Fig. 1 , inhibition of TBXAS activity with increasing levels of furegrelate significantly increased StAR promoter activity, with the promoter activity being increased 4-fold as the concentration of furegrelate was increased from 0 to 0.8 mm in the culture with 0.2 mm dbcAMP (Fig. 2B) . Paralleling the increase in StAR promoter activity, a concentration-dependent increase in StAR mRNA level was detected by RT-PCR analysis ( Fig. 2A) .
RNAi in TBXAS expression
To verify the role of TBXAS in StAR gene expression and steroidogenesis, TBXAS expression was specifically inhib- MA-10 cells were cultured in serum-free Waymouth's medium with increasing concentrations of the TBX A synthase inhibitor furegrelate for 30 min, and then 0.2 mM dbcAMP was added to the culture for 6 h. A, Cells were collected for total RNA isolation, and StAR mRNA was analyzed by RT-PCR with ␤-actin as an internal marker. The StAR-or ␤-actinspecific bands were quantitated as IOD and expressed as average of StAR/␤-actin IOD ratio for each treatment. *, P Ͻ 0.05, n ϭ 3, compared with 0.2 mM dbcAMP alone. B, MA-10 cells were transfected with a StAR promoter/luciferase plasmid (PGL2/StAR) and a pRLSV40 vector DNA, a plasmid that constitutively expresses Renilla luciferase. The cell lysate was used for luciferase assays using a dual luciferase reporter assay system. The RLU was determined by dividing the reading from the PGL2/StAR promoter by the reading from Renilla luciferase. The promoter activity was expressed as fold over RLU of control. *, P Ͻ 0.05, n ϭ 3; ***, P Ͻ 0.001, n ϭ 3; compared with 0.2 mM dbcAMP alone.
ited using RNAi. Although the control siRNA did not affect TBXAS expression, transfection with TBXAS siRNA significantly reduced TBXAS mRNA levels in MA-10 cells (Fig.  3A) . Although the transfection with control siRNA seemed to slightly increase StAR mRNA, StAR mRNA levels in MA-10 cells were increased significantly by TBXAS siRNA over that of the siRNA control (Fig. 3B ). These observations were corroborated by the results from Western blot analyses of StAR protein expression and RIA for steroidogenesis by MA-10 cells. As shown in Fig. 4 , inhibition of TBXAS expression by RNAi increased StAR protein and steroidogenesis, with progesterone production being significantly increased 3.2-fold over that of the siRNA control.
Blocking TBX A2-binding to its receptor enhanced steroidogenesis
To determine whether the TBXAS-generated AA metabolite TBX A2 was involved in the observed inhibitory effect, MA-10 cells were incubated with 10 m SQ29548, a highly selective antagonist of TBX A2 receptor (33), for 30 min, and then 0.2 mm dbcAMP was added to the culture for 6 h. The results from the experiments indicated that although 0.2 mm dbcAMP alone did not induce a significant increase in steroidogenesis, coincubation of MA-10 cells with 10 m of this receptor antagonist dramatically increased StAR protein expression (Fig. 5A) . As StAR protein increased, steroid hormone production increased 8.5-fold over that of the cells treated with 0.2 mm dbcAMP alone (Fig. 5B) . MA-10 cells were transfected with siRNA corresponding to the TBXAS DNA sequence 5Ј-CCCAAGATGGTAGCAGACA-3Ј or control siRNA using the X-tremeGENE siRNA transfection reagent. The cells were cultured for 3 d and then treated as indicated in the figure for 6 h. The cells were collected for total RNA isolation. TBXAS mRNA and StAR mRNA were analyzed by RT-PCR using ␤-actin as an internal marker. A, RT-PCR analysis of TBXAS mRNA levels. The TBXAS or ␤-actin-specific bands were quantitated as IOD and expressed as average of TBXAS/␤-actin IOD ratio for each treatment. *, P Ͻ 0.05, n ϭ 3, compared with siRNA control. B, RT-PCR analysis of StAR mRNA levels. The StAR-or ␤-actin-specific bands were quantitated as IOD and expressed as average of StAR/␤-actin IOD ratio for each treatment. *, P Ͻ 0.05, n ϭ 5, compared with the group without dbcAMP; **, P Ͻ 0.05, n ϭ 5, compared with siRNA control. 
RT-PCR analysis of StAR mRNA
Synergistic interaction between cAMP and the TBXAS inhibitor in steroidogenesis
To further understand the role of TBXAS in steroidogenesis, MA-10 cells were incubated with or without 0.8 mm furegrelate for 30 min, and then increasing levels of dbcAMP were added to the culture for 6 h. In the absence of dbcAMP, inhibition of TBXAS activity with 0.8 mm furegrelate did not significantly increase StAR protein and steroidogenesis. However, addition of 0.05 mm dbcAMP to the MA-10 cell culture with the inhibitor dramatically increased steroid hormone production and StAR protein expression (Fig. 6) . The steroidogenic effects of the TBXAS inhibitor were further enhanced by increasing concentrations of dbcAMP from 0.05 to 0.25 mm. The results shown in Fig. 6 illustrate that low levels of dbcAMP alone (0.05-0.1 mm) were unable to induce significant increases in StAR protein and steroid hormone. However, the effectiveness of such low levels of dbcAMP was dramatically enhanced by inhibition of TBXAS activity, with 0.1 mm dbcAMP inducing higher levels of StAR protein and steroidogenesis than those induced by 0.5 mm dbcAMP alone. In the presence of the TBXAS inhibitor, dbcAMP at 0.05, 0.1, and 0.25 mm increased progesterone productions by 25-, 44-, and 12-fold, respectively, over those stimulated with the same levels of dbcAMP alone (Fig. 6B) . Also, StAR protein expression and steroid hormone production reached to the maximal levels at much lower levels of dbcAMP.
Essential role of PKA activity in the inhibitorincreased steroidogenesis
The above results and our previous observations encouraged us to determine the role of PKA activity in the increased steroidogenesis. PKA activity was inhibited using a PKA inhibitor, H89, in the culture of MA-10 cells treated with 0.2 mm dbcAMP and 0.8 mm furegrelate. Similar to the results described above, inhibition of TBXAS activity dramatically increased steroidogenesis. However, inhibition of PKA activity essentially abolished the furegrelate-increased StAR protein expression (Fig. 7A) . Steroid hormone production was reduced to 21% of that induced by dbcAMP and the TBXAS inhibitor (Fig. 7B) .
DAX-1 expression
To further understand how TBXAS affects StAR gene transcription, the level of DAX-1 protein was analyzed. Results obtained from Western blot analyses indicated that inhibition of TBXAS activity markedly reduced DAX-1 protein (Fig. 8A) . Also, StAR mRNA levels were analyzed by RT-PCR to determine the relationship between the reduced DAX-1 protein and StAR gene transcription. As shown in Fig. 8 , the reduction in DAX-1 protein is associated with a significant increase in StAR mRNA levels.
Discussion
Studies in recent years have demonstrated a COX2-dependent inhibition of StAR gene expression and steroidogenesis in testicular Leydig cells, but the mechanism responsible for the inhibitory effects of COX2 has not yet been elucidated. In COX2-mediated AA metabolism, AA is converted to PGH2, which is further metabolized to PGD2, PGE2, PGF2␣, PGI2, and TBX A2 by the downstream enzymes, the prostaglandin synthases, and TBXAS. Following previous studies that reported an inhibitory effect of PGF2␣ on steroidogenesis (18, 19) , the present study suggests an inhibitory effect of TBXAS on StAR gene expression in MA-10 mouse Leydig cells.
This inhibitory effect of TBXAS on StAR gene expression was supported by several lines of experimentation in the present study. The results obtained from these experiments indicated that inhibition of TBXAS activity, using the specific inhibitor furegrelate, dramatically increased StAR promoter activity, StAR mRNA levels, StAR protein expression, and steroid hormone production in MA-10 Leydig cells. The inhibitory effect of TBXAS on steroidogenesis was corroborated by specific inhibition of TBXAS expression using TBXAS siRNA. The RNAi-reduced TBXAS expression was indicated by a significant decrease in TBXAS mRNA levels as detected by RT-PCR analysis. The results of the present study demonstrated that the RNAi-mediated inhibition of TBXAS expression significantly increased StAR mRNA levels, StAR protein, and steroid hormone production. The above observations were further strengthened when MA-10 cells were treated with a highly selective antagonist of TBX A2 receptor, with StAR protein and steroid production being dramatically increased by the receptor antagonist.
The manner in which TBXAS acts to inhibit StAR protein expression is unknown. The results from RT-PCR analysis of StAR mRNA levels and luciferase assays of StAR promoter activities indicated that the TBXAS inhibitor increased StAR protein by enhancing StAR gene transcription. Similar results were obtained when TBXAS expression was inhibited by RNAi, with StAR mRNA levels being increased as TBXAS mRNA levels in the cells were decreased. We attempted to find a possible explanation for the increase in StAR gene transcription elicited by the TBXAS inhibitor. Interestingly, inhibition of TBXAS activity markedly reduced DAX-1, a protein reported to bind to a hairpin structure in StAR promoter and inhibit StAR gene transcription (21) . Although more studies are needed, these results suggested a possible effect of TBXAS activity on the level of DXA-1 protein in MA-10 cells.
Whereas inhibition of TBXAS activity dramatically increased cAMP-induced StAR protein expression and steroid hormone production, in the absence of cAMP or after inhibition of PKA activity, the TBXAS inhibitor alone was unable to induce significant increases in steroidogenesis and StAR protein. However, when TBXAS activity was inhibited, the steroidogenic sensitivity of MA-10 mouse Leydig cells was dramatically increased, with subthreshold levels of dbcAMP being able to induce maximal levels of StAR protein expression and steroidogenesis. This observation indicated that the inhibitor itself is not able to stimulate steroidogenesis, but rather reduced the threshold for cAMP-induced StAR gene expression. Similar observations were obtained in MA-10 cells treated with a COX2 inhibitor as previously reported (16) . Results from the present and previous studies suggest that the combined activities of COX2 and TBXAS produce AA metabolites that control the threshold of trophic hormone-stimulated steroidogenesis by depressing StAR gene transcription.
Taken all together, these studies provide an opportunity for better understanding of the signal transduction in trophic hormone-stimulated steroidogenesis. The studies indicate that trophic hormone stimulation induces not only positive signals but also negative signals in StAR gene expression. In the AA-mediated signaling pathway, the positive signals are produced by lipoxygenase (15, 34 -37) and epoxygenase (14, 38, 39) , whereas the negative signals are generated by COX2 and by the downstream enzymes PGF synthase (19, 20, 22) and TBXAS as described above. In the cAMP-PKA-phosphorylation pathway, PKA phosphorylates the transcription factors that enhance StAR gene transcription (2) . On the other hand, PKA may also induce negative signals. For example, a previous study reported hCG-induced increase in COX2 expression in Leydig cells (19) . This observation was corroborated by a recent study on LH-or cAMP-stimulated steroidogenesis, in which LH-induced rise in COX2 protein levels was nearly abolished by inhibition of PKA activity (40) . These studies suggested that cAMP-PKA phosphorylation may be required for LH-induced COX2 expression. Therefore, the total effect of trophic hormone on StAR gene expression seems to depend on the levels and ratios of positive and negative signals in Leydig cells. Obviously, the LHstimulated increase in StAR protein in that study was due to the increased positive signals that produced stronger steroidogenic effects than the increased negative signals (40) , such as COX2-produced metabolites, which opposed it. It is possible that when LH stimulates StAR gene expression, it also induces feedback signaling, involving AA metabolites generated by COX2, PGF synthase, and TBXAS, to control StAR gene expression.
In summary, following previous studies that reported the inhibitory effects of AA metabolites produced by COX2-PGF synthase on steroidogenesis, the present study suggests that COX2 and TBXAS also act in concert to depress StAR gene transcription, possibly by being involved in the expression or stability of DAX-1, a StAR gene repressor.
